Three peptides derived from diazepam-binding inhibitor (DBI), an endogenous ligand for the benzodiazcpine receptor, were isolated from an extract of frog brain and their primary structures were determined. On the basis of the amino acid sequence data, a cDNA encoding frog DBI was isolated from a whole brain cDNA library. This cDNA was used to study DBI gene expression in various frog tissues by Northern blot analysis, RT-PCR and in situ hybridization.
Benzodiazcpines
are pharmacological agents that are widely used for their anxiolytic, anticonvulsivant, muscle relaxant and sedative properties. The biological effects of benzodiazepines are mediated through two types of receptors, the GABAA-benzodiazepine receptor complex and the peripheral-type benzodiazepine receptor (PBR) located in mitochondrial membranes. Despite an intensive search involving sequence analysis of more than 70 peptides from the brain extract, the peptide fragment corresponding to DBI-(40-57) was not identified. In order to obtain the complete sequence, a frog brain cDNA library ( 1 06 recombinants) was prepared and screened with a set of degenerate (32-fold) oligonucleotides designed from amino acid residues 22-27 (DDELKE) of frog DBI. A cDNA clone gave the whole coding region (267 nt) (LIHRMANN et al., 1994) . The deduced amino acid sequence of frog DBI exhibits two important features. First, a high degree of interspecies conservation; frog DBI shares 80% identity with duck DBI and 61 % to 68% identity with various mammalian DBIs ( fig. 1 ). This strongly suggests that DBI belongs to an important and evolutionary well conserved family of regulatory peptides. Second, the absence of a signal peptide, i.e. the polypeptide DBI-(1-39) represents the N-terminal portion of the open reading frame. This latter observation is consistent with the fact that DBI is synthesized and stored exclusively in glial cells that are virtually devoid of secretory vesicles.
DBI gene expression has been detected in frog brain by Northern blot analysis whereas all pcripheral tissues examined were virtually devoid of signal (LIHRMANN et al., 1994) . However, the combined use of reverse transcription followed by the polymerase chain reaction (RT-PCR), a method which is 1,000-10,000 fold more sensitive than the traditional RNA blot techniques, made it possible to detect DBI transcripts in many peripheral organs, including testis, intestine and lung, and to a lesser extent in adrenal gland, kidney, heart and liver. Immunohistochemical studies (MALAGON et al., 1992) and in situ hybridization (LIHRMANN et al., 1994) have shown that, in the frog brain, the DBI gene is expressed in ependymal cells and circumventricular organs lining the ventricular cavity. Since DBI is released from cultured astrocytes (M. LAMACZ, M.C. TONON, F. ROUET-SMITH, C. PATTE, P. GASQUE, M. FONTAINE and H. VAUDRY, unpublishcd results) and since glial cells possess both GABAA and PBR receptors, these data suggest that DBI acts through an autocrine and/or paracrine mechanism.
